Finding the ‘Guilty’ Gene Variant of Sporadic Parkinson’s Disease Via CRISPR/Cas9

被引:0
|
作者
Shenzhao Lu
Jiawei Zhou
机构
[1] Chinese Academy of Sciences,Institute of Neuroscience, State Key Laboratory of Neuroscience, Shanghai Institutes for Biological Sciences
来源
Neuroscience Bulletin | 2017年 / 33卷
关键词
Parkinson’s disease; Genetic variant; CRISPR/Cas9;
D O I
暂无
中图分类号
学科分类号
摘要
Parkinson’s disease (PD) is a common neurodegenerative disorder affecting millions of people worldwide, but its cause and pathogenesis are still not fully understood. Earlier studies have shown that SNCA, which encodes α-synuclein, is one of the key genes associated with PD. Single-nucleotide polymorphism (SNP) variants of SNCA are thought to be correlated with disease onset. The underlying mechanisms however are enigmatic. A recent study published in Nature revealed that one of the SNP variants in the SNCA non-coding element elevated α-synuclein expression in human neurons by reducing the binding efficiency of transcription factors, demonstrating a previously uncharted role for SNPs in the pathogenesis of PD.
引用
收藏
页码:115 / 117
页数:2
相关论文
共 50 条
  • [1] Finding the ‘Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9
    Shenzhao Lu
    Jiawei Zhou
    Neuroscience Bulletin, 2017, (01) : 115 - 117
  • [2] Finding the 'Guilty' Gene Variant of Sporadic Parkinson's Disease Via CRISPR/Cas9
    Lu, Shenzhao
    Zhou, Jiawei
    NEUROSCIENCE BULLETIN, 2017, 33 (01) : 115 - 117
  • [3] CRISPR/Cas9 Toolbox for the Study of Parkinson's Disease
    Sandoval, I. M.
    Daley, B.
    Kuhn, N.
    Marckini, N.
    Strauss, A. C.
    Lipton, J. W.
    Manfredsson, F. P.
    Collier, T. J.
    CELL TRANSPLANTATION, 2016, 25 (04) : 771 - 771
  • [4] CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
    Pinjala, Poojitha
    Tryphena, Kamatham Pushpa
    Prasad, Renuka
    Khatri, Dharmendra Kumar
    Sun, Woong
    Singh, Shashi Bala
    Gugulothu, Dalapathi
    Srivastava, Saurabh
    Vora, Lalitkumar
    BIOMATERIALS RESEARCH, 2023, 27 (01)
  • [5] Application of CRISPR/Cas9 in the management of Alzheimer's disease and Parkinson's disease: a review
    Thapar, Nandita
    Eid, Mosab Ahmad Fathi
    Raj, Nishchita
    Kantas, Theodosios
    Billing, Harbir S.
    Sadhu, Dhavalkumar
    ANNALS OF MEDICINE AND SURGERY, 2024, 86 (01): : 329 - 335
  • [6] CRISPR/Cas9 assisted stem cell therapy in Parkinson's disease
    Poojitha Pinjala
    Kamatham Pushpa Tryphena
    Renuka Prasad
    Dharmendra Kumar Khatri
    Woong Sun
    Shashi Bala Singh
    Dalapathi Gugulothu
    Saurabh Srivastava
    Lalitkumar Vora
    Biomaterials Research, 27
  • [7] CRISPR/CAS9 GENE EDITING
    不详
    CHEMICAL & ENGINEERING NEWS, 2015, : 26 - 27
  • [8] CRISPR/Cas9 and gene therapy
    Giono, Luciana E.
    MEDICINA-BUENOS AIRES, 2017, 77 (05) : 405 - 409
  • [9] Application of CRISPR/Cas9 in Alzheimer's Disease
    Lu, Likui
    Yu, Xi
    Cai, Yongle
    Sun, Miao
    Yang, Hao
    FRONTIERS IN NEUROSCIENCE, 2021, 15
  • [10] CRISPR/CAS9 GENE EDITING APPLICATIONS IN CARDIOVASCULAR DISEASE
    Khouzam, J.
    Khouzam, R.
    Tivakaran, V.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 423 - 424